FDA Approves Companion Diagnostic for Colorectal Cancer Treatment
The FDA has approved a companion diagnostic for identifying BRAF V600E-mutant metastatic colorectal cancer patients eligible for encorafenib combination therapy.
Category: Cancer
Cancer
Latest
Cancer
Latest
HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Cancer
Latest
Reducing the Cost of Cancer Care with Improved Diagnostics
Better cancer testing can help patients avoid unnecessary scans and biopsies, while also lowering costs for the healthcare system.
Ultrasensitive ctDNA Test Shows Promise for Lung Cancer Monitoring
A study of 431 patients demonstrates the test can detect cancer recurrence months ahead of standard imaging.
Read More
Study Identifies Factors That Interfere with Cancer Detection in Liquid Biopsy
Research analyzing cell-free DNA fragmentation patterns in healthy individuals reveals physiological confounders that could improve test accuracy.
Read More
Natera Acquires Foresight Diagnostics in $450 Million Deal
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read More
New Partnership Aims to Expand Access to AI-Driven Cancer Genomic Testing
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Read More
ACS Updates Cervical Cancer Screening Guidelines, Adds HPV Self-Collection Option
The new guidelines allow self-collected vaginal samples for HPV testing and outline criteria for safely discontinuing cervical cancer screening.
Read More
FDA Approves Blood-Based Prostate Cancer Test
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
Read More
Blood Test May Match CT for Early Lung Cancer Detection
The Mercy Halo test demonstrates performance similar to low-dose CT screening with the potential to reach underscreened populations.
Read More
New Somatic Cancer Reference Standards Launched to Monitor Diagnostic Assay Accuracy
The standards developed through a public-private partnership contain seven oncogenic mutations selected for clinical significance.
Read More
Medicare Covers Ultrasensitive MRD Test for Breast Cancer Surveillance
Coverage applies to stage II and III breast cancer patients across three major subtypes for up to six years of recurrence monitoring.
Read More
New Data Shows How Plasma Detect Assay May Support Cancer Treatment Decisions
Research demonstrates the MRD assay’s utility in tracking disease progression and predicting treatment outcomes.
Read More
Cancer Check Labs Expands Multi-Cancer Detection Test to New York
The blood-based screening test can detect more than 200 types of solid tumor cancers and is now available in all 48 continental states.
Read More
Plus Therapeutics Secures Humana Coverage for CNS Cancer Assay
The agreement extends CNSide cerebrospinal fluid test coverage to 16 million additional patients nationwide.
Read More
MyOme Launches Integrated Polygenic Risk Score for Prostate Cancer
The whole-genome test combines data from 7 million genetic markers with clinical risk factors to provide individualized 10-year and lifetime risk assessments.
Read More
Lunit, Labcorp Partner on AI-Powered Digital Pathology Research
The collaboration combines Labcorp’s clinical expertise with Lunit’s AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Read More
BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening
The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- ...
- 189